Colorectal Cancer
Cancer of the colon or rectum — among the most common cancers worldwide and a major focus of screening and drug development.
Coverage of Colorectal Cancer is holding steady : 45 signals on the latest tracked day, down 69% from its three-week baseline of 147, across 3 domains (unchanged from a week ago). That makes it the #1 most-covered of the 348 concerns we track.
What’s changed
5 of the last 7 tracked days ran below the three-week baseline — a sustained cooling, not a one-day dip.
- Serum Pharmacochemistry Combined With Network Pharmacology to Explore Potential Bioactive Components and Mechanisms of Pomegranate Peel in the Treatment of Colorectal Cancer. · Biomed Chromatogr · 2026-10-01
- [Articles] Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial · The Lancet Oncology · 2026-09-30
- Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial. · Lancet Oncol · 2026-09-01
- Discovery and synthesis of 3-amino glycyrrhizin derivative containing guanidyl with anti-colorectal cancer activity. · Chin J Nat Med · 2026-09-01
- Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial · Journal of Clinical Oncology · 2026-08-30
- Genomic Landscape of Early-Onset Colorectal Cancer: A Comparative Analysis With Average-Onset Metastatic Colorectal Cancer in a Real-World NGS Cohort · JCO Precision Oncology · 2026-08-30
What the reporting says
It shows up alongside Immunotherapy (200), ctDNA (105), KRAS (99), Braf (69), MSI-H (53), Systematic Review (45), Egfr (43), Wang (63).
Two steps out: Lung Cancer (through KRAS, 65 shared stories on the weaker link); China (through Wang, 60 shared stories on the weaker link); G12d (through KRAS, 60 shared stories on the weaker link); Pancreatic Cancer (through KRAS, 51 shared stories on the weaker link).
Tracked since Jul 21, with coverage on 175 separate days — concentrated in Pubmed Targeted and Oncology.